BPH Symptom Score Questionnaire

Wooden blocks spell the word prostate

Interactive Tool: BPH Symptom Score Questionnaire

This tool is for individuals with a prostate who are experiencing lower urinary tract symptoms. It asks about your about your urinary symptoms from BPH and gives you a score based on how severe your symptoms are. Your score on this questionnaire may help you think about if and how you want to treat the problem. The score is called the International Prostate Symptom Score (IPSS) and is based on the American Urological Association (AUA) Symptom Index.1 It is commonly used to screen for, evaluate, track the symptoms of, and suggest management of the symptoms of benign prostatic hyperplasia (BPH).

1McVary KT, et al. (2010). Guideline on the management of benign prostatic hyperplasia (PH). In American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH)., pp. 2-34. Linthicum, MD: American Urological Association Education and Research.

Over the last month, how often have you:

Had the feeling of not completely emptying your bladder after you finished urinating?(Required)
Had to urinate again less than 2 hours after you finished urinating?(Required)
Found that you stopped and started again several times while urinating?(Required)
Found it hard to hold your urine?(Required)
Had a weak urine stream?(Required)
Had to push or strain to begin urination?(Required)
Had to get up to urinate during the night?(Required)

Human Health News

Omega-3 fatty acids may protect brain health

Recent studies highlight the potential role of omega-3 fatty acids in protecting brain health, especially among older adults. These essential fats, found in fatty fish like salmon, offer benefits for heart health, inflammation, and brain function. Now, two studies suggest they may also benefit individuals at higher risk for cognitive decline, such as carriers of the ε4 allele of the apolipoprotein E gene (APOE4).

Read More

Iron deficiency and anemia are hidden ailments in women

Despite the high prevalence of iron deficiency and anemia in women in their reproductive years, it is still widely underdiagnosed and undertreated. Anemia can result in poorer outcomes in pregnancy. Diagnosis involves routine blood tests, and treatment may include diet changes, oral iron supplements, or intravenous iron.

Read More

How Scientists Plan on Eliminating Alzheimer’s Disease

Breakthroughs in Alzheimer’s disease research offer hope for the successful treatment – and elimination – of the disease. This was the finding of New Scientist journalist Graham Lawton, who reviewed the history and status of research on dementia and Alzheimer’s disease. In particular, exciting new Alzheimer’s vaccine research holds promise for preventing Alzheimer’s disease.

Read More

Omega-3 fatty acids may protect brain health

Recent studies highlight the potential role of omega-3 fatty acids in protecting brain health, especially among older adults. These essential fats, found in fatty fish like salmon, offer benefits for heart health, inflammation, and brain function. Now, two studies suggest they may also benefit individuals at higher risk for cognitive decline, such as carriers of the ε4 allele of the apolipoprotein E gene (APOE4).

Read More

Iron deficiency and anemia are hidden ailments in women

Despite the high prevalence of iron deficiency and anemia in women in their reproductive years, it is still widely underdiagnosed and undertreated. Anemia can result in poorer outcomes in pregnancy. Diagnosis involves routine blood tests, and treatment may include diet changes, oral iron supplements, or intravenous iron.

Read More

How Scientists Plan on Eliminating Alzheimer’s Disease

Breakthroughs in Alzheimer’s disease research offer hope for the successful treatment – and elimination – of the disease. This was the finding of New Scientist journalist Graham Lawton, who reviewed the history and status of research on dementia and Alzheimer’s disease. In particular, exciting new Alzheimer’s vaccine research holds promise for preventing Alzheimer’s disease.

Read More

Shingles vaccine may lower dementia risk

The recombinant zoster vaccine known as SHINGRIX may also lower the risk of developing dementia, according to a new study. The vaccine prevents shingles, a painful viral infection, and is typically recommended for those 50 and older. Researchers in the U.K. published a study in Nature Medicine on July 25 that showed that among people diagnosed with dementia, those who received the recombinant zoster vaccine had more diagnosis-free time compared with those who received a different vaccine.

Read More
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today